Evidence map›Paper›PMID 33731484›Full record

ArticleBMJ open quality2021

Improving intravenous-to-oral antibiotic switch in children: a team-based audit and implementation approach.

Brendan Joseph McMullan, Michelle Mahony, Lolita Java, Mona Mostaghim, Michael Plaister, Camille Wu, Sophie White, Laila Al Yazidi, Erica Martin, Penelope Bryant and 2 more

Abstract read
In one paragraph

Article in BMJ open quality, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brendan Joseph McMullanDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia b.mcmullan@unsw.edu.au.ORCID 0000-0001-5144-3416
Michelle MahonyDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Lolita JavaMedication Safety, Clinical Excellence Commission, Sydney, New South Wales, Australia.
Mona MostaghimPharmacy Department, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Michael PlaisterDepartment of General Paediatrics, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Camille WuSchool of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.
Sophie WhiteDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Laila Al YazidiDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Erica MartinDepartment of Nursing, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.
Penelope BryantInfectious Diseases and Hospital in the Home Departments, The Royal Children's Hospital, Melbourne, Victoria, Australia.
Karin A ThurskyNHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Evette BuonoMedication Safety, Clinical Excellence Commission, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children in hospital are frequently prescribed intravenous antibiotics for longer than needed. Programmes to optimise timely intravenous-to-oral antibiotic switch may limit excessive in-hospital antibiotic use, minimise complications of intravenous therapy and allow children to go home faster. Here, we describe a quality improvement approach to implement a guideline, with team-based education, audit and feedback, for timely, safe switch from intravenous-to-oral antibiotics in hospitalised children. Eligibility for switch was based on evidence-based guidelines and supported by education and feedback. The project was conducted over 12 months in a tertiary paediatric hospital. Primary outcomes assessed were the proportion of eligible children admitted under paediatric and surgical teams switched within 24 hours, and switch timing prior to and after guideline launch. Secondary outcomes were hospital length of stay, recommencement of intravenous therapy or readmission. The percentage of children switched within 24 hours of eligibility significantly increased from 32/50 (64%) at baseline to 203/249 (82%) post-implementation (p=0.006). The median time to switch fell from 15 hours 42 min to 4 hours 20 min (p=0.0006). In addition, there was a 14-hour median reduction in hospital length of stay (p=0.008). Readmission to hospital and recommencement of intravenous therapy did not significantly change postimplementation. This education, audit and feedback approach improved timely intravenous-to-oral switch in children and also allowed for more timely discharge from hospital. The study demonstrates proof of concept for this implementation with a methodology that can be readily adapted to other paediatric inpatient settings.

Indexed as

Anti-Bacterial AgentsPatient DischargeAdministration, IntravenousChildHospitalizationHumansTertiary Care CentersAnti-Bacterial Agentsantibiotic managementaudit and feedbackhealthcare quality improvementpaediatricsteamwork

Identifiers

PMID33731484
PMCPMC7978100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.